Literature DB >> 3310654

Control of late G0/G1 progression and protein modification by SmC/IGF I.

N E Olashaw1, J J Van Wyk, W J Pledger.   

Abstract

Somatomedin C/insulin-like growth factor I (SmC/IGF I) mediates traverse of late G0/G1 in density-arrested BALB/c-3T3 cells from a distinct growth arrest point in mid-G0/G1 (the V point) to the initiation of DNA synthesis. As a prelude to future studies aimed at defining the mechanism of action of SmC/IGF I, we investigated the level (e.g., transcriptional, translational) at which SmC/IGF I modulates V to S traverse. The post-V point progression of cells arrested at the V point by amino acid starvation and released into amino acid-replenished medium containing SmC/IGF I, insulin, or platelet-poor plasma (PPP) did not require either mRNA synthesis or an increase in the overall level of protein synthesis. Although two-dimensional gel analysis of proteins prepared from SmC/IGF I-treated cells did not reveal any preferentially synthesized proteins, several SmC/IGF I-induced protein modifications, which result in an increase in isoelectric point (pI) and occur in the absence of mRNA synthesis, were evident. These findings suggest that SmC/IGF I modulates late G0/G1 progression by a posttranscriptional process that may involve protein modification.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3310654     DOI: 10.1152/ajpcell.1987.253.4.C575

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  beta-catenin mediates insulin-like growth factor-I actions to promote cyclin D1 mRNA expression, cell proliferation and survival in oligodendroglial cultures.

Authors:  Ping Ye; Qichen Hu; Hedi Liu; Yun Yan; A Joseph D'ercole
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

3.  Insulinlike growth factor-1 is a progression factor for human mesangial cells.

Authors:  T Doi; L J Striker; S J Elliot; F G Conti; G E Striker
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Platelet-derived growth factor induces apoptosis in growth-arrested murine fibroblasts.

Authors:  H R Kim; S Upadhyay; G Li; K C Palmer; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

5.  Regulation of rat mesangial cell growth by diadenosine phosphates.

Authors:  S Heidenreich; M Tepel; H Schlüter; B Harrach; W Zidek
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

6.  Down-regulation of programmed cell death 5 by insulin-like growth factor 1 in osteoarthritis chondrocytes.

Authors:  Chengqing Yi; Chunhui Ma; Zongping Xie; Guoqiao Zhang; Wangsheng Song; Xiaokai Zhou; Yun Cao
Journal:  Int Orthop       Date:  2013-01-16       Impact factor: 3.075

7.  Dilong: role in peripheral nerve regeneration.

Authors:  Yung-Ming Chang; Wei-Yi Chi; Tung-Yuan Lai; Yueh-Sheng Chen; Fuu-Jen Tsai; Chang-Hai Tsai; Wei-Wen Kuo; Yi-Chang Cheng; Chien-Chung Lin; Chih-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-15       Impact factor: 2.629

8.  Alpinia oxyphylla Miq. fruit extract activates IGFR-PI3K/Akt signaling to induce Schwann cell proliferation and sciatic nerve regeneration.

Authors:  Yung-Ming Chang; Hen-Hong Chang; Chin-Chuan Tsai; Hung-Jen Lin; Tsung-Jung Ho; Chi-Xin Ye; Ping-Ling Chiu; Yueh-Sheng Chen; Ray-Jade Chen; Chih-Yang Huang; Chien-Chung Lin
Journal:  BMC Complement Altern Med       Date:  2017-03-31       Impact factor: 3.659

9.  RSC96 Schwann Cell Proliferation and Survival Induced by Dilong through PI3K/Akt Signaling Mediated by IGF-I.

Authors:  Yung-Ming Chang; Wu-Hsien Kuo; Tung-Yuan Lai; Ying-Ting Shih; Fuu-Jen Tsai; Chang-Hai Tsai; Wen-Tong Shu; Ying-Yu Chen; Yueh-Sheng Chen; Wei-Wen Kuo; Chih-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-08       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.